Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03813836 |
|---|---|
| Brief Title: | Phase II Trial of Pembrolizumab in Recurrent or Metastatic HNSCC (POPPY) |
| First Submitted : | January 15, 2019 |
| First Submitted that Met QC Criteria : | January 22, 2019 |
| First Posted : | January 23, 2019 |
| Last Update Submitted that Met QC Criteria : | May 30, 2022 |
| Last Update Posted : | June 2, 2022 |